Antibiotx ApS - Company Review
Antibiotx ApS - Company ReviewSummary
AntibioTx ApS (AntibioTx) develops novel class of antibiotics for the treatment of bacterial infections and related disorders. Its lead product candidate, ATx201, is a small molecule being developed for the topical treatment of treatment of skin infections and microbiome-related dermatological disorders. The company’s product pipeline includes ATx202 and ATx401. ATx202 is a small molecule with properties that are suitable for cutaneous delivery. It is being developed for the treatment of acne in terms of in vitro spectrum of effect and delayed onset of de novo resistance. ATx401 is an oral treatment that inhibits spore formation in Clostridium difficile at a fixed level compared to the minimum inhibitory concentration. AntibioTx is headquartered in Kongens Lyngby, Denmark.
This comprehensive company report of Antibiotx ApS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.